Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6476
PUT
FuelCell Energy
FCEL
$1.73B
| $1.5M | ﹤0.01% |
204,900
-122,100
| -37% | -$998K |
|
6477
Federal Agricultural Mortgage
AGM
$2.47B
| $1.5M | ﹤0.01% |
8,530
-25,474
| -75% | -$4.28M |
|
6478
Celldex Therapeutics
CLDX
$2.99B
| $1.5M | ﹤0.01% |
55,101
-264,231
| -83% | -$6.96M |
|
6479
Bank First Corp
BFC
$1.69B
| $1.5M | ﹤0.01% |
+12,281
| New | +$1.56M |
|
6480
PUT
Immunovant
IMVT
$7.93B
| $1.49M | ﹤0.01% |
58,800
-31,800
| -35% | -$709K |
|
6481
PUT
Gold Royalty Corp
GROY
$600M
| $1.49M | ﹤0.01% |
369,500
+156,500
| +73% | +$599K |
|
6482
Riskified
RSKD
$694M
| $1.49M | ﹤0.01% |
300,226
+172,785
| +136% | +$832K |
|
6483
Byrna Technologies
BYRN
$103M
| $1.49M | ﹤0.01% |
88,818
-163,376
| -65% | -$3.18M |
|
|
6484
FuelCell Energy
FCEL
$1.73B
| $1.49M | ﹤0.01% |
203,964
+157,307
| +337% | +$1.29M |
|
|
GRNY
6485
PUT
FundStrat Granny Shots US Large Cap ETF
GRNY
$4.29B
| $1.49M | ﹤0.01% |
60,200
+17,500
| +41% | +$440K |
|
6486
Unicycive Therapeutics
UNCY
$137M
| $1.49M | ﹤0.01% |
258,301
+216,627
| +520% | +$1.16M |
|
|
SVM
6487
CALL
Silvercorp Metals
SVM
$2.07B
| $1.49M | ﹤0.01% |
178,700
-43,300
| -20% | -$315K |
|
|
MFSB
6488
MFS Active Core Plus Bond ETF
MFSB
$520M
| $1.49M | ﹤0.01% |
59,082
-33,030
| -36% | -$836K |
|
6489
Fidelity Stocks for Inflation ETF
FCPI
$273M
| $1.49M | ﹤0.01% |
30,098
+7,946
| +36% | +$397K |
|
6490
PUT
Pampa Energía
PAM
$4.75B
| $1.49M | ﹤0.01% |
16,800
-168,700
| -91% | -$13.6M |
|
|
ATXS
6491
DELISTED
Astria Therapeutics
ATXS
| $1.49M | ﹤0.01% |
113,555
-735,427
| -87% | -$8.78M |
|
6492
CALL
American Battery Technology Co
ABAT
$285M
| $1.49M | ﹤0.01% |
444,800
+160,100
| +56% | +$749K |
|
6493
CALL
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
| $1.49M | ﹤0.01% |
41,000
-15,200
| -27% | -$551K |
|
|
DRD
6494
CALL
DRDGold
DRD
$1.77B
| $1.49M | ﹤0.01% |
47,900
-22,300
| -32% | -$637K |
|
6495
PUT
Array Technologies
ARRY
$803M
| $1.48M | ﹤0.01% |
161,000
-16,600
| -9% | -$142K |
|
6496
PUT
Immunome
IMNM
$2.58B
| $1.48M | ﹤0.01% |
69,100
+49,500
| +253% | +$869K |
|
|
SLN
6497
Silence Therapeutics
SLN
$495M
| $1.48M | ﹤0.01% |
244,061
+222,556
| +1,035% | +$1.42M |
|
6498
ActivePassive US Equity ETF
APUE
$2.42B
| $1.48M | ﹤0.01% |
35,553
+14,502
| +69% | +$600K |
|
6499
CALL
Bakkt Inc
BKKT
$321M
| $1.48M | ﹤0.01% |
147,532
-162,452
| -52% | -$3.59M |
|
6500
PUT
AMN Healthcare
AMN
$1.3B
| $1.48M | ﹤0.01% |
93,900
-400
| -0.4% | -$7.14K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.